BECTON, DICKINSON AND COMPANY Payments for Restructuring
BECTON, DICKINSON AND COMPANY (BDX) reported Payments for Restructuring of $131.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY payments for restructuring for the quarter ending 2026-06-30 was $37.00M, a 31.48% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments for restructuring for the quarter ending 2026-03-31 was $36.00M, a 7.69% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments for restructuring for the quarter ending 2025-12-31 was $58.00M, a 10.77% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments for restructuring for the quarter ending 2025-09-30 was $73.00M, a 14.12% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments for restructuring for fiscal 2025 was $231.00M, a 24.26% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY payments for restructuring for fiscal 2024 was $305.00M, a 84.85% increase from fiscal 2023.
- BECTON, DICKINSON AND COMPANY payments for restructuring for fiscal 2023 was $165.00M, a 101.22% increase from fiscal 2022.
- BECTON, DICKINSON AND COMPANY payments for restructuring for fiscal 2022 was $82.00M, a 46.43% increase from fiscal 2021.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2026-06-30 | $37.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $73.00M derived: sum of 2 quarters · filed 2026-08-06 | $131.00M 10-Q · filed 2026-08-06 | $204.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $94.00M 10-Q · filed 2026-05-07 | $167.00M derived: sum of 3 quarters · filed 2026-05-07 | $221.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $58.00M 10-Q · filed 2026-02-09 | $131.00M derived: sum of 2 quarters · filed 2026-02-09 | $185.00M derived: sum of 3 quarters · filed 2026-02-09 | $224.00M derived: sum of 4 quarters · filed 2026-02-09 |
| 2025-09-30 | $73.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $127.00M derived: sum of 2 quarters · filed 2025-11-25 | $166.00M derived: sum of 3 quarters · filed 2025-11-25 | $231.00M 10-K · filed 2025-11-25 |
| 2025-06-30 | $54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $93.00M derived: sum of 2 quarters · filed 2025-08-07 | $158.00M 10-Q · filed 2025-08-07 | $243.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2025-03-31 | $39.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-01 | $104.00M 10-Q · filed 2025-05-01 | $189.00M derived: sum of 3 quarters · filed 2025-11-25 | $265.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-12-31 | $65.00M 10-Q · filed 2025-02-06 | $150.00M derived: sum of 2 quarters · filed 2025-11-25 | $226.00M derived: sum of 3 quarters · filed 2025-11-25 | $305.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-09-30 | $85.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $161.00M derived: sum of 2 quarters · filed 2025-11-25 | $240.00M derived: sum of 3 quarters · filed 2025-11-25 | $305.00M 10-K · filed 2025-11-25 |
| 2024-06-30 | $76.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-01 | $155.00M derived: sum of 2 quarters · filed 2024-08-01 | $220.00M 10-Q · filed 2024-08-01 | $288.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $79.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-02 | $144.00M 10-Q · filed 2024-05-02 | $212.00M derived: sum of 3 quarters · filed 2025-11-25 | $249.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $65.00M 10-Q · filed 2024-02-01 | $133.00M derived: sum of 2 quarters · filed 2025-11-25 | $170.00M derived: sum of 3 quarters · filed 2025-11-25 | $204.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $105.00M derived: sum of 2 quarters · filed 2025-11-25 | $139.00M derived: sum of 3 quarters · filed 2025-11-25 | $165.00M 10-K · filed 2025-11-25 |
| 2023-06-30 | $37.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-03 | $71.00M derived: sum of 2 quarters · filed 2023-08-03 | $97.00M 10-Q · filed 2023-08-03 | $125.00M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $34.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-04 | $60.00M 10-Q · filed 2023-05-04 | $88.00M derived: sum of 3 quarters · filed 2024-11-27 | $104.00M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $26.00M 10-Q · filed 2023-02-02 | $54.00M derived: sum of 2 quarters · filed 2024-11-27 | $70.00M derived: sum of 3 quarters · filed 2024-11-27 | $88.00M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | $28.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $44.00M derived: sum of 2 quarters · filed 2024-11-27 | $62.00M derived: sum of 3 quarters · filed 2024-11-27 | $82.00M 10-K · filed 2024-11-27 |
| 2022-06-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | $34.00M derived: sum of 2 quarters · filed 2022-08-04 | $54.00M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05 | $38.00M 10-Q · filed 2022-05-05 | ||
| 2021-12-31 | $20.00M 10-Q · filed 2022-02-03 | |||
| 2021-09-30 | $56.00M 10-K · filed 2023-11-21 | |||
| 2020-09-30 | $80.00M 10-K · filed 2022-11-22 | |||
| 2017-09-30 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | $12.00M derived: sum of 2 quarters · filed 2017-11-22 | $29.00M derived: sum of 3 quarters · filed 2017-11-22 | $57.00M 10-K · filed 2017-11-22 |
| 2017-06-30 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $28.00M derived: sum of 2 quarters · filed 2017-08-03 | $56.00M 10-Q · filed 2017-08-03 | $92.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2017-03-31 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-02 | $45.00M 10-Q · filed 2017-05-02 | $81.00M derived: sum of 3 quarters · filed 2017-11-22 | $109.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2016-12-31 | $28.00M 10-Q · filed 2017-02-02 | $64.00M derived: sum of 2 quarters · filed 2017-11-22 | $92.00M derived: sum of 3 quarters · filed 2017-11-22 | $144.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2016-09-30 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | $64.00M derived: sum of 2 quarters · filed 2017-11-22 | $116.00M derived: sum of 3 quarters · filed 2017-11-22 | $148.00M 10-K · filed 2017-11-22 |
| 2016-06-30 | $28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-04 | $80.00M derived: sum of 2 quarters · filed 2016-08-04 | $112.00M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $52.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-06 | $84.00M 10-Q · filed 2016-05-06 | ||
| 2015-12-31 | $32.00M 10-Q · filed 2016-02-05 | |||
| 2015-09-30 | $94.00M 10-K · filed 2017-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |